Growth Metrics

Ginkgo Bioworks Holdings (DNA) Consolidated Net Income: 2020-2025

Historic Consolidated Net Income for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$80.8 million.

  • Ginkgo Bioworks Holdings' Consolidated Net Income fell 43.18% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 47.86%. This contributed to the annual value of -$547.0 million for FY2024, which is 38.73% up from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Consolidated Net Income is -$80.8 million, which was down 33.92% from -$60.3 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Consolidated Net Income ranged from a high of -$54.5 million in Q2 2021 and a low of -$1.6 billion during Q4 2021.
  • Its 3-year average for Consolidated Net Income is -$152.0 million, with a median of -$165.9 million in 2024.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first plummeted by 3,359.12% in 2021, then skyrocketed by 89.22% in 2022.
  • Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Consolidated Net Income stood at -$1.6 billion in 2021, then spiked by 89.22% to -$173.1 million in 2022, then declined by 22.31% to -$211.7 million in 2023, then soared by 49.20% to -$107.5 million in 2024, then plummeted by 43.18% to -$80.8 million in 2025.
  • Its Consolidated Net Income stands at -$80.8 million for Q3 2025, versus -$60.3 million for Q2 2025 and -$91.0 million for Q1 2025.